sEH活动与ARDS患者的死亡率有关:一项回顾性队列研究
Dong Guangsu1, Zhou Liang1, Wang Bin1
1Department of Intensive Care Unit, No. 3 People's Hospital of Xuzhou, Jiangsu Province, 221000, China.
Biomarkers in medicine
|August 13, 2024
概括
血中较高的可溶性环氧化酶 (sEH) 活性与急性呼吸困扰综合征 (ARDS) 患者的死亡风险增加有关. 这一发现可能有助于预测患者的结果.
科学领域:
- 生物医学科学 生物医学科学
- 临床医学 临床医学
- 心血管研究研究心血管研究
背景情况:
- 急性呼吸窘迫综合征 (ARDS) 是一种具有高死亡率的危急病.
- 溶性环氧化酶 (sEH) 在炎症过程中起作用.
- 需要预测ARDS死亡率的生物标志物.
研究的目的:
- 研究ARDS患者的血SEH活性和28天死亡率之间的关联.
- 确定血SEH活性是否可以作为ARDS死亡率的预测指标.
主要方法:
- 包括在2017年至2019年期间被诊断患有ARDS的成年患者.
- 血样本被分析为SEH活动.
- 记录了28天死亡率,并与sEH活动水平相关联.
主要成果:
- 总共有337名ARDS患者被研究,其中107人在28天内死亡.
- 与幸存者相比,未幸存者表现出显著更高的血SEH活性.
- 接收器操作特征 (ROC) 曲线显示曲线下的面积 (AUC) 为0.81,用于预测28天死亡率.
结论:
- 血SEH活性升高与ARDS患者28天死亡率的增加显著相关.
- 血SEH活性显示出作为ARDS死亡率预测生物标志物的潜力.
- 对ARDS治疗的sEH调制进行进一步的研究是有必要的.
相关概念视频
01:23Acute Respiratory Failure-IV
133
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
133
01:21Acute Respiratory Failure-II
192
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
192